Researchers of synthetic biology based at the Massachusetts Institute of Technology (MIT) in the US have devised a system to protect the gut microbiome from the effects of antibiotics.
The new study, published, reports on the successful use in mice of a “live biotherapeutic” – a genetically engineered bacterium that produces an enzyme which breaks down antibiotics in the gut.
